ClinicalTrials HQ

United Kingdom

United Kingdom

Explore linked clinical trials.

1,503 results · Page 1 of 61

Cities

Swipe the table sideways for more columns.

CitiesCityCountryLinked trials
AbercynonAbercynonUnited Kingdom4
AberdeenAberdeenUnited Kingdom1
AberdeenAberdeenUnited Kingdom2
AberdeenAberdeenUnited Kingdom13
AberdeenAberdeenUnited Kingdom124
AberdeenAberdeenUnited Kingdom1
AberdeenAberdeenUnited Kingdom10
AberdeenAberdeenUnited Kingdom2
AberdeenAberdeenUnited Kingdom1
AberdeenAberdeenUnited Kingdom19
AberdeenAberdeenUnited Kingdom1
AbergavennyAbergavennyUnited Kingdom4
AbergavennyAbergavennyUnited Kingdom1
AberystwythAberystwythUnited Kingdom2
AberystwythAberystwythUnited Kingdom2
ActonActonUnited Kingdom1
AddlestoneAddlestoneUnited Kingdom1
AddlestoneAddlestoneUnited Kingdom1
AdstoneAdstoneUnited Kingdom1
AintreeAintreeUnited Kingdom4
AirdrieAirdrieUnited Kingdom13
AirdrieAirdrieUnited Kingdom1
AirdrieAirdrieUnited Kingdom1
AirdrieAirdrieUnited Kingdom6
AirdrieAirdrieUnited Kingdom1

5,307 results · Page 1 of 213

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Grief Support App for Adults Experiencing BereavementAlzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathyNot yet recruitingNot applicable2026-10-09NCT07862244
A Study Investigating Gingival Crevicular Fluid Biomarkers Following Use of a Commercially Available Toothpaste Containing Stannous FluorideDental Deposits, Dental Plaque, Infections, Stomatognathic Diseases, gingival disorder, gingivitis, mouth disorder, periodontal disorder, tooth disorderRecruitingNot applicable2026-10-09NCT07842042
Early Probiotic Research: Open-label Functional Intervention and Longitudinal Evaluation in Healthy AdultsHealthy Adult Participants; Probiotic InterventionNot yet recruitingNot applicable2026-10-09NCT07841457
Market Research of a Slow Release Protein Substitute for the Dietary Management of PKUBrain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, nervous system disorder, phenylketonuriaNot yet recruitingNot applicable2026-10-09NCT07802366
Prescribing the Right Agent for Depression in Adultsdepressive disorder, major depressive disorder, mood disorder, psychiatric disorderNot yet recruitingNot applicable2026-10-09NCT07796295
Wearable for Assessing Tremor and Continuous Health in Parkinson's Disease and Essential TremorDyskinesias, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathyRecruitingNot stated2026-10-09NCT07787299
Exploratory Study of Peristomal and Non-Peristomal Skin Barrier Characteristics in People With a StomaColostomy - Stoma; Ileostomy - Stoma; UrostomyRecruitingNot stated2026-10-09NCT07719309
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaDigestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic adenocarcinoma, pancreatic ductal adenocarcinoma, pancreatic neoplasmRecruitingPhase 32026-10-09NCT07562152
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 32026-10-09NCT07554339
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypotrichosis, skin disorderRecruitingPhase 22026-10-09NCT07533006
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 32026-10-09NCT07513376
Study of INCA036978 in Participants With Myeloproliferative NeoplasmsHemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Site, acquired polycythemia vera, blood coagulation disease, blood platelet disease, bone marrow disorder, bone marrow neoplasm, essential thrombocythemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, neoplasm, primary myelofibrosis, thrombocytosis diseaseRecruitingPhase 12026-10-09NCT07441694
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib StudiesSolid TumorsRecruitingPhase 22026-10-09NCT07415031
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorderRecruitingPhase 32026-10-09NCT07284849
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary FibrosisFibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorderRecruitingPhase 22026-10-09NCT07284459
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical PracticeDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasmRecruitingNot stated2026-10-09NCT07284121
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid ArthritisSkin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritisRecruitingPhase 22026-10-09NCT07276581
AZD0486 1L Therapy for Elderly or Unfit Participants With LBCLlarge B-cell lymphomaRecruitingPhase 32026-10-09NCT07215585
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 OverexpressionAdnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorderRecruitingPhase 32026-10-09NCT07214779
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)Progressive Metastatic Castrate Resistant Prostate CancerRecruitingPhase 1 / Phase 22026-10-09NCT07206056
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)Bronchiolitis Obliterans, bronchial disorder, bronchiolitis, bronchiolitis obliterans syndrome, bronchitis, cryptogenic organizing pneumonia, graft versus host disease, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorderRecruitingPhase 22026-10-09NCT07124078
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 2 / Phase 32026-10-09NCT07100080
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, digestive system disorder, digestive system neoplasm, gastric neoplasm, lethal congenital contracture syndrome 2, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, stomach disorderRecruitingPhase 1 / Phase 22026-10-09NCT07070232
A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand DiseaseCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, von Willebrand disease (hereditary or acquired), von Willebrand disease 3RecruitingPhase 32026-10-09NCT06998524
EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)PIK3CA-related Overgrowth Spectrum (PROS)RecruitingPhase 22026-10-09NCT06997588